Back to search

Article

Inhibiting LRRK2 kinase activity protects against the pathology associated with the presenilin 1 Ile416Thr mutation in cholinergic neurons

2025-09-19

Abstract excerpt

Familial Alzheimer’s disease (FAD) is an accelerated form of dementia that affects cholinergic neurons. Unfortunately, despite several efforts, no single drug or treatment has shown complete efficacy. Therefore, it is imperative to find effective therapeutic agents. Previously, it has been shown that the PSEN1 I416T variant induces FAD-like neuropathology in cholinergic-like neurons (ChLNs), which is characterized...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
a63fab72-bc8a-53be-89c0-526b0607d367
DOI
10.1101/2025.09.17.25336024
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Inhibiting LRRK2 kinase activity protects against the pathology associated with the presenilin 1 Ile416Thr mutation in cholinergic neuronsDOI 10.1101/2025.09.17.25336024
Select a neighboring publication to make it the new centre.